NM_032776.3:c.2347A>C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032776.3(JMJD1C):c.2347A>C(p.Thr783Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,864 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. T783T) has been classified as Benign.
Frequency
Consequence
NM_032776.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JMJD1C | ENST00000399262.7 | c.2347A>C | p.Thr783Pro | missense_variant | Exon 8 of 26 | 5 | NM_032776.3 | ENSP00000382204.2 | ||
JMJD1C | ENST00000542921.5 | c.1801A>C | p.Thr601Pro | missense_variant | Exon 7 of 25 | 1 | ENSP00000444682.1 | |||
JMJD1C | ENST00000402544.5 | n.2319A>C | non_coding_transcript_exon_variant | Exon 5 of 22 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249144Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135150
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461720Hom.: 1 Cov.: 33 AF XY: 0.0000523 AC XY: 38AN XY: 727144
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74330
ClinVar
Submissions by phenotype
Early myoclonic encephalopathy Uncertain:1
This sequence change replaces threonine with proline at codon 783 of the JMJD1C protein (p.Thr783Pro). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and proline. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with JMJD1C-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at